Evaluation Value of Intravoxel Incoherent Motion Diffusion-Weighted Imaging on Early Efficacy of Magnetic Resonance-Guided High-Intensity Focused Ultrasound Ablation for Uterine Adenomyoma

To investigate the evaluation value of intravoxel incoherent motion diffusion-weighted imaging (IVIM-DWI) on the early efficacy of magnetic resonance-guided high-intensity focused ultrasound (MRgFUS) ablation for uterine adenomyoma. The clinical and magnetic resonance imaging (MRI) data of 36 patients with uterine adenomyoma before and after MRgFUS treatment in our hospital from January 2018 to December 2018 were retrospectively analyzed. All the 36 patients underwent MRI examination one day before operation and immediately after operation using GE Discovery MR750 3.0T MRI, including conventional sequences (T1WI, T2WI, and T2 fat suppression sequences) plain scan, IVIM-DWI sequences with 9 b values, and contrast enhanced-MRI sequences. The IVIM-DWI quantitative parameters (true diffusion coefficient D, perfusion related diffusion coefficient D*, and perfusion fraction f) of double-exponential model were obtained by using GE ADW 4.7 functool, a postprocessor. SPSS 24.0 software was used to analyze the difference in parameter between the ablation and non-ablation areas of uterine adenomyoma. DWI signal in the ablation area of uterine adenomyoma was increased, and manifested as heterogeneous diffuse high signal, with low central signal and high edge signal. Values of D, D* and f in the ablation area of uterine adenomyoma were significantly lower than those in the non-ablation area, and there was statistical difference between the two (P < 0.05). The areas under receiver operating characteristic (ROC) curve of D, D* and f values in the ablation area of uterine adenomyoma were 0.854, 0.898 and 0.924, respectively; the optimal thresholds for the diagnosis of ablation area of uterine adenomyoma were 0.81 × 10−3 mm2/s, 4.99 × 10−3 mm2/s and 0.24, respectively; the diagnostic sensitivity was 80.6%, 72.2% and 94.4%, respectively; and the specificity was 91.7%, 97.2% and 94.4%, respectively. IVIM-DWI has a certain clinical value in the evaluation on early efficacy of MRgFUS ablation of uterine adenomyosis.